Evidence map›Paper›PMID 41918955›Full record

ArticleOpen forum infectious diseases2026

Sabrine Douiyeb, Wendy van Gameren, David Buis, Thomas van der Vaart, Matthijs Boekholdt, Jasper Selder, Danielle Robbers-Visser, Hein Verberne, Henri van Werkhoven, Kim Sigaloff and 1 more

Abstract read
In one paragraph

Article in Open forum infectious diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Sabrine DouiyebDepartment of Internal Medicine, Amsterdam UMC, Amsterdam, The Netherlands.ORCID https://orcid.org/0000-0002-2533-4627
Wendy van GamerenDepartment of Internal Medicine, Meander Medical Center, Amersfoort, The Netherlands.
David BuisDepartment of Internal Medicine, Amsterdam UMC, Amsterdam, The Netherlands.ORCID https://orcid.org/0000-0002-0830-8670
Thomas van der VaartDepartment of Internal Medicine, Amsterdam UMC, Amsterdam, The Netherlands.ORCID https://orcid.org/0000-0002-5873-0474
Matthijs BoekholdtDepartment of Cardiology, Amsterdam UMC, Amsterdam, The Netherlands.ORCID https://orcid.org/0000-0002-0861-0765
Jasper SelderDepartment of Cardiology, Amsterdam UMC, Amsterdam, The Netherlands.
Danielle Robbers-VisserDepartment of Cardiology, Amsterdam UMC, Amsterdam, The Netherlands.
Hein VerberneDepartment of Radiology and Nuclear Medicine, Amsterdam UMC, Location AMC, University of Amsterdam, Amsterdam, The Netherlands.ORCID https://orcid.org/0000-0003-3774-2414
Henri van WerkhovenJulius Center for Health Sciences and Primary Care, UMC Utrecht, Utrecht University, Utrecht, The Netherlands.
Kim SigaloffDepartment of Internal Medicine, Amsterdam UMC, Amsterdam, The Netherlands.
Jan PrinsDepartment of Internal Medicine, Amsterdam UMC, Amsterdam, The Netherlands.ORCID https://orcid.org/0000-0002-5415-8933

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Extracardiac complications (ECCs) contribute to morbidity and mortality in patients with infective endocarditis (IE). Current guidelines recommend Methods: Patients with possible or definite IE (European Society of Cardiology 2015 criteria) were prospectively enrolled in the Amsterdam UMC endocarditis team registry from October 2016 till March 2021. The primary outcome, the number of source control interventions (SCIs), was analyzed using Cox regression analyses extended for recurrent events, with Results: We included 252 patients, 152 in the Conclusions: The use of

Indexed as

18F-FDG-PET/CTextracardiac complicationsinfective endocarditissource control interventions

Identifiers

PMID41918955
PMCPMC13034731

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.